Autonomix Medical (NASDAQ:AMIX) Posts Earnings Results

Autonomix Medical (NASDAQ:AMIX) announced its earnings results on Wednesday. The company reported ($1.38) earnings per share for the quarter, Zacks reports.

Autonomix Medical Stock Performance

Shares of NASDAQ AMIX traded down $0.00 during midday trading on Wednesday, hitting $0.85. 54,795 shares of the stock traded hands, compared to its average volume of 572,756. The firm has a market capitalization of $5.25 million, a P/E ratio of -0.15 and a beta of -2.76. Autonomix Medical has a one year low of $0.75 and a one year high of $14.06. The firm has a 50-day moving average of $1.08 and a two-hundred day moving average of $1.35.

Analyst Ratings Changes

AMIX has been the topic of several recent research reports. Zacks Research downgraded Autonomix Medical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Autonomix Medical in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Autonomix Medical to a “sell” rating in a report on Saturday, July 26th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Autonomix Medical presently has an average rating of “Hold” and a consensus target price of $5.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.